Ongoing research aims to delineate its full spectrum of activity, optimal strategies, and the breadth of its implications.

Research conducted at the Suez Canal University endocrinology outpatient clinic in Ismailia City, Egypt and released in 2024, ...

This initiative aligns with Sandoz’s ongoing efforts to support Egypt’s Vision 2030 and local healthcare authorities’ ...

Topline data were announced from a phase 3 trial evaluating somapacitan in children born small for gestational age, with Noonan syndrome, or with idiopathic short stature.

Somapacitan is a human growth hormone analog currently marketed ... failure due to inadequate secretion of endogenous growth hormone (GH), and for the replacement of endogenous GH in adults ...

Acromegaly is characterized by excessive growth hormone (GH) and insulin-like growth factor 1 (IGF-1) and affects quality of life and mortality. Oczyesa was submitted in a hybrid application ...

Researchers conducted a cross-sectional analysis to assess the effect of untreated adult growth hormone deficiency among adult survivors of childhood cancer.

Biochemical control of acromegaly in noncured patients is usually defined as serum growth hormone (GH) levels <2.0 µg/l, plus normal-for-age serum levels of insulin-like growth factor I (IGF-I).

The top reasons weight loss supplements fail and why most solutions don't address both day and night fat-burning cycles; How PhenQ works as a powerful daytime fat burner to help r ...

Of particular recent interest is the growth hormone (GH)/insulin-like growth factor-I (IGF-I) system. In the context of skeletal muscle homoeostasis, IGF-I is thought to mediate the majority of the ...